Noninvasive Assessment of Fibrosis Regression after Direct-acting Antiviral Treatment in Hepatitis C Virus Patients

Yana Davidov; Yeruham Kleinbaum; Yael Inbar; Oranit Cohen-Ezra; Ella Veitsman; Peretz Weiss; Mariya Likhter; Tania Berdichevski; Sima Katsherginsky; Avishag Hassid; Keren Tsaraf; Dana Silverberg; Ziv Ben Ari

Noninvasive Assessment of Fibrosis Regression after Direct-acting Antiviral Treatment in Hepatitis C Virus Patients

Yana Davidov^*, Yeruham Kleinbaum, Yael Inbar, Oranit Cohen-Ezra, Ella Veitsman, Peretz Weiss, Mariya Likhter, Tania Berdichevski, Sima Katsherginsky, Avishag Hassid, Keren Tsaraf, Dana Silverberg, Ziv Ben Ari

^*Corresponding author for this work

Internal Medicine

Sheba Medical Center at Tel Hashomer

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Abstract

Background: New direct acting antiviral agent (DAA) therapies are associated with a high sustained virological response rate (SVR) in hepatitis C virus (HCV) patients. The understanding of the impact of SVR on fibrosis stage is limited.

Original language	English
Pages (from-to)	794-800
Number of pages	7
Journal	Israel Medical Association Journal
Volume	23
Issue number	12
State	Published - Dec 2021

Keywords

Chronic hepatitis C virus (HCV)
Direct acting antiviral agent (DAA)
Liver fibrosis regression
Noninvasive assessment
Shear-wave elastography (see editorial page XXX)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{97abec9abd07453e8cc936abe685f9b8,

title = "Noninvasive Assessment of Fibrosis Regression after Direct-acting Antiviral Treatment in Hepatitis C Virus Patients",

abstract = "Background: New direct acting antiviral agent (DAA) therapies are associated with a high sustained virological response rate (SVR) in hepatitis C virus (HCV) patients. The understanding of the impact of SVR on fibrosis stage is limited.",

keywords = "Chronic hepatitis C virus (HCV), Direct acting antiviral agent (DAA), Liver fibrosis regression, Noninvasive assessment, Shear-wave elastography (see editorial page XXX)",

author = "Yana Davidov and Yeruham Kleinbaum and Yael Inbar and Oranit Cohen-Ezra and Ella Veitsman and Peretz Weiss and Mariya Likhter and Tania Berdichevski and Sima Katsherginsky and Avishag Hassid and Keren Tsaraf and Dana Silverberg and Ari, {Ziv Ben}",

note = "Publisher Copyright: {\textcopyright}. Methods: Fibrosis stage was determined at baseline and at 6-month intervals after end of treatment (EOT), using two-dimensional SWE or FibroTest",

year = "2021",

month = dec,

language = "אנגלית",

volume = "23",

pages = "794--800",

journal = "Israel Medical Association Journal",

issn = "1565-1088",

publisher = "Israel Medical Association",

number = "12",

}

TY - JOUR

T1 - Noninvasive Assessment of Fibrosis Regression after Direct-acting Antiviral Treatment in Hepatitis C Virus Patients

AU - Davidov, Yana

AU - Kleinbaum, Yeruham

AU - Inbar, Yael

AU - Cohen-Ezra, Oranit

AU - Veitsman, Ella

AU - Weiss, Peretz

AU - Likhter, Mariya

AU - Berdichevski, Tania

AU - Katsherginsky, Sima

AU - Hassid, Avishag

AU - Tsaraf, Keren

AU - Silverberg, Dana

AU - Ari, Ziv Ben

N1 - Publisher Copyright: ©. Methods: Fibrosis stage was determined at baseline and at 6-month intervals after end of treatment (EOT), using two-dimensional SWE or FibroTest

PY - 2021/12

Y1 - 2021/12

N2 - Background: New direct acting antiviral agent (DAA) therapies are associated with a high sustained virological response rate (SVR) in hepatitis C virus (HCV) patients. The understanding of the impact of SVR on fibrosis stage is limited.

AB - Background: New direct acting antiviral agent (DAA) therapies are associated with a high sustained virological response rate (SVR) in hepatitis C virus (HCV) patients. The understanding of the impact of SVR on fibrosis stage is limited.

KW - Chronic hepatitis C virus (HCV)

KW - Direct acting antiviral agent (DAA)

KW - Liver fibrosis regression

KW - Noninvasive assessment

KW - Shear-wave elastography (see editorial page XXX)

UR - http://www.scopus.com/inward/record.url?scp=85122907226&partnerID=8YFLogxK

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

C2 - 34954919

AN - SCOPUS:85122907226

SN - 1565-1088

VL - 23

SP - 794

EP - 800

JO - Israel Medical Association Journal

JF - Israel Medical Association Journal

IS - 12

ER -

Noninvasive Assessment of Fibrosis Regression after Direct-acting Antiviral Treatment in Hepatitis C Virus Patients

Abstract

Keywords

UN SDGs

Other files and links

Fingerprint

Cite this